Eversept Partners’s Equillium EQ Stock Holding History

Eversept Partners’s Portfolio EQ Stock Details EQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.87M	Buy	1,520,824 +21,831	+1%	+$52.3K	0.25%	68
2026 Q1	$3M	Buy	+1,498,993	New	+$2.47M	0.16%	75

Other funds holding EQ

Jupiter Topco New York $245B AUM

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Eversept Partners's EQ Position: Q2 2026 in Review

Eversept Partners increased its Equillium (EQ) stake by 1.5% in Q2 2026, buying an estimated $52.3K and bringing the position to 1,520,824 shares worth $4.87M. The position accounts for 0.25% of the portfolio, ranked #68.

Eversept Partners first reported a position in EQ in Q1 2026 and has held it in 2 quarters since. 60 funds tracked by Wall St. Rank hold EQ as of Q2 2026.

Eversept Partners held 1,520,824 shares of Equillium worth $4.87M as of Q2 2026.
Eversept Partners bought 21,831 Equillium shares in Q2 2026, an estimated $52.3K.
Equillium made up 0.25% of Eversept Partners's portfolio in Q2 2026, its #68 holding.
Eversept Partners first reported a position in Equillium in Q1 2026 and has held it in 2 quarters since.
60 funds tracked by Wall St. Rank held Equillium as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.